In the NAFLD “portal theory,” there is an exacerbated release of FFAs, endotoxins, and proinflammatory cytokines of visceral fat that reach the liver, via portal system, promoting the development of liver resistance to insulin, hepatic steatosis, and inflammation in obese individuals [16, 18]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.